Metsera

Metsera Quick Ratio

Delisted

The Quick Ratio (Acid Test) of Metsera (MTSR) as of Nov 4, 2026 is 4.86. In the previous year, Quick Ratio (Acid Test) was 3.62 — a change of 34.35% (higher).

Quick Ratio

4.86

YoY

34.35%

Last updated:

Quick Ratio (Acid Test) of Metsera is 2024 4.86 . Quick Ratio (Acid Test) of Metsera was 2023 3.62 . It decreases by 34.35% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Quick Ratio (Acid Test) of Metsera is 4.86 in 2024.

Quick Ratio (Acid Test) of Metsera changed from 3.62 to 4.86, representing a 34.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Metsera since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Metsera with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Metsera

All Key Metrics — Metsera